Elicio Therapeutics ELTX
NASDAQ ELTX
$1.67 +0.10 (+6.37%)
At close: Oct 21, 2026 · 4:00 PM EDT

Elicio Therapeutics (ELTX) Share-based Compensation (2020 - 2026)

Updated

Elicio Therapeutics' Share-based Compensation came in at $935,000 for Q2 2026, up 31.7% from $710,000 a year earlier and up 7.7% from the prior quarter.

Analysis

Elicio Therapeutics (ELTX) Share-based Compensation (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Elicio Therapeutics reported Share-based Compensation of $3.27 million, up 63.2% year-over-year; for FY2025, it came in at $2.7 million, up 85.7% from FY2024.

  • Share-based Compensation has increased in each of the last three years, though with a five-year compound annual growth rate of -10.6% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $1.45 million in FY2024 (+23.2%), $1.18 million in FY2023 (+103.6%), $579,000 in FY2022 (-95.2%) and $12.04 million in FY2021 (+155.3%).
  • The Q2 2026 figure represents the highest quarterly Share-based Compensation since Q4 2021.
  • Year-over-year, Share-based Compensation has increased for seven consecutive quarters, with growth averaging 60.1% over the last eight quarters.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q1 2023 (growth of 622.6%), and the weakest in Q1 2022 (a decline of 99.4%).
  • Business Quant data shows ELTX's Share-based Compensation at $868,000 (Q1 2026), $772,000 (Q4 2025) and $698,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 458.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 166.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 231.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 249.00 Mn
10 Elicio Therapeutics 31.85 Mn -45.77 Mn - 935,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 935,000.00
Mar 31, 2026 868,000.00
Dec 31, 2025 772,000.00
Sep 30, 2025 698,000.00
Jun 30, 2025 710,000.00
Mar 31, 2025 517,000.00
Dec 31, 2024 464,000.00
Sep 30, 2024 314,000.00
Jun 30, 2024 350,000.00
Mar 31, 2024 324,000.00
Dec 31, 2023 337,000.00
Sep 30, 2023 339,000.00
Jun 30, 2023 279,000.00
Mar 31, 2023 224,000.00
Dec 31, 2022 199,000.00
Sep 30, 2022 110,000.00
Jun 30, 2022 239,000.00
Mar 31, 2022 31,000.00
Dec 31, 2021 2.02 Mn
Sep 30, 2021 2.18 Mn
API Access

Elicio Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ELTX&period=max&api_key=YOUR_API_KEY